NEW YORK, Oct. 19 (GenomeWeb News) - Althea Technologies has received a $100,000 Phase I SBIR grant from the National Cancer Institute to help develop validated, quantitative gene-expression assays for multiple pediatric cancers.


To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.